GlobeNewswire Inc.··NaBavarian Nordic Wins Swiss Approval for Chikungunya Vaccine VIMKUNYA
Bavarian Nordic secures Swiss regulatory approval for chikungunya vaccine VIMKUNYA, marking fourth major market clearance in 2025 following FDA, EMA, and MHRA approvals.
BVNRYregulatory milestonevaccine development